VSIG4, a B7 family-related protein, is a negative regulator of T cell activation

Journal of Clinical Investigation

Volumn 116, Issue 10, 2006, Pages 2817-2826

  Vogt, Lorenz ^a   Schmitz, Nicole ^a   Kurrer, Michael O ^b   Bauer, Monika ^a   Hinton, Heather I ^a   Behnke, Silvia ^b   Gatto, Dominique ^a   Sebbel, Peter ^a   Beerli, Roger R ^a   Sonderegger, Ivo ^c   Kopf, Manfred ^c   Saudan, Philippe ^a   Bachmann, Martin F ^a  

^a CYTOS BIOTECHNOLOGY AG   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERLEUKIN 2; PROTEIN KINASE; PROTEIN VSIG4; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD80; AUTOIMMUNE DISEASES; CELL LINE; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULINS; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-2; LIPOPOLYSACCHARIDES; LIVER; LYMPHOCYTE ACTIVATION; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYOCARDITIS; PEPTIDES; RECEPTORS, COMPLEMENT; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES; THIOGLYCOLATES;

EID: 33749444763     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI25673     Document Type: Article

References (53)

1. Langman, R.E., and Cohn, M. 1993. Two signal models of lymphocyte activation? Immunol. Today. 14:235-237.
2. Lenschow, D.J., Walunas, T.L., and Bluestone, J.A. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
3. Chambers, C.A., and Allison, J.P. 1999. Costimulatory regulation of T cell function. Curr. Opin. Cell Biol. 11:203-210.
4. Schwartz, R.H. 2003. T cell anergy. Annu. Rev. Immunol. 21:305-334.
5. Sharpe, A.H., and Freeman, G.J. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:116-126.
6. Coyle, A.J., and Gutierrez-Ramos, J.C. 2001. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2:203-209.
7. Viola, A., and Lanzavecchia, A. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science. 273:104-106.
8. Bachmann, M.F., et al. 1997. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity. 7:549-557.
9. Hutloff, A., et al. 1999. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 397:263-266.
10. Yoshinaga, S.K., et al. 1999. T-cell co-stimulation through B7RP-1 and ICOS. Nature. 402:827-832.
11. Coyle, A.J., et al. 2000. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity. 13:95-105.
12. Tafuri, A., et al. 2001. ICOS is essential for effective T-helper-cell responses. Nature. 409:105-109.
13. Kopf, M., et al. 2000. Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J. Exp. Med. 192:53-61.
14. Bertram, E.M., et al. 2002. Role of ICOS versus CD28 in antiviral immunity. Eur. J. Immunol. 32:3376-3385.
15. Suh, W.K., et al. 2004. The inducible costimulator plays the major costimulatory role in humoral immune responses in the absence of CD28. J. Immunol. 172:5917-5923.
16. Mak, T.W., et al. 2003. Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat. Immunol. 4:765-772.
17. Ishida, Y., Agata, Y., Shibahara, K., and Honjo, T. 1992. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11:3887-3895.
18. Latchman, Y., et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2:261-268.
19. Freeman, G.J., et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192:1027-1034.
20. Dong, H., Zhu, G., Tamada, K., and Chen, L. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5:1365-1369.
21. Tseng, S.Y., et al. 2001. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193:839-846.
22. Watanabe, N., et al. 2003. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4:670-679.
23. Sedy, J.R., et al. 2005. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 6:90-98.
24. Chapoval, A.I., et al. 2001. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat. Immunol. 2:269-274.
25. Sica, G.L., et al. 2003. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity. 18:849-861.
26. Prasad, D.V., Richards, S., Mai, X.M., and Dong, C. 2003. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity. 18:863-873.
27. Sun, M., et al. 2002. Characterization of mouse and human B7-H3 genes. J. Immunol. 168:6294-6297.
28. Suh, W.K., et al. 2003. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat. Immunol. 4:899-906.
29. Langnaese, K., Colleaux, L., Kloos, D.U., Fontes, M., and Wieacker, P. 2000. Cloning of Z39Ig, a novel gene with immunoglobulin-like domains located on human chromosome X. Biochim. Biophys. Acta. 1492:522-525.
30. Ahn, J.H., et al. 2002. Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis. Blood. 100:1742-1754.
31. Walker, M.G. 2002. Z39Ig is co-expressed with activated macrophage genes. Biochim. Biophys. Acta. 1574:387-390.
32. Kim, J.K., et al. 2005. Characterization of monoclonal antibody specific to the Z39Ig protein, a member of immunoglobulin superfamily. Immunol. Lett. 99:153-161.
33. Eriksson, U., et al. 2003. Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis. J. Exp. Med. 197:323-331.
34. Jegerlehner, A., et al. 2002. Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation. Eur. J. Immunol. 32:3305-3314.
35. Storni, T., et al. 2004. Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J. Immunol. 172:1777-1785.
36. Gatto, D., Ruedl, C., Odermatt, B., and Bachmann, M.F. 2004. Rapid response of marginal zone B cells to viral particles. J. Immunol. 173:4308-4316.
37. Khoury, S.J., and Sayegh, M.H. 2004. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity. 20:529-538.
38. Chen, L. 2004. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4:336-347.
39. Bonifaz, L., et al. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196:1627-1638.
40. Probst, H.C., Lagnel, J., Kollias, G., and van den Broek, M. 2003. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity. 18:713-720.
41. Marengere, L.E., et al. 1996. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science. 272:1170-1173.
42. Lee, K.M., et al. 1998. Molecular basis of T cell inactivation by CTLA-4. Science. 282:2263-2266.
43. Bachmann, M.F., et al. 1998. Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. J. Immunol. 160:95-100.
44. Chambers, C.A., Sullivan, T.J., Truong, T., and Allison, J.P. 1998. Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur. J. Immunol. 28:3137-3143.
45. Bluestone, J.A. 1997. Is CTLA-4 a master switch for peripheral T cell tolerance? J. Immunol. 158:1989-1993.
46. Bachmann, M.F., Kohler, G., Ecabert, B., Mak, T.W., and Kopf, M. 1999. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163:1128-1131.
47. Bachmann, M.F., et al. 2001. Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered. Eur. J. Immunol. 31:450-458.
48. Tivol, E.A., and Gorski, J. 2002. Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4. J. Immunol. 169:1852-1858.
49. Greenwald, R.J., Boussiotis, V.A., Lorsbach, R.B., Abbas, A.K., and Sharpe, A.H. 2001. CTLA-4 regulates induction of anergy in vivo. Immunity. 14:145-155.
50. Helmy, K.Y., et al. 2006. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell. 124:915-927.
51. Durbin, R., Eddy, S., Kroegh, A., and Mitchison, G. 1998. Biological sequence analysis: probabilistic models of proteins and nucleic acids. Cambridge University Press. New York, New York, USA. 356 pp.
52. Letunic, I., et al. 2002. Recent improvements to the SMART domain-based sequence annotation resource. Nucleic Acid Res. 30:242-244.
53. Nielsen, H., Engelbrecht, J., Brunak, S., and von Heijne, G. 1997. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 10:1-6.